保乳术结合新辅助化疗法治疗乳腺癌的效果

Effect of Breast Conserving Surgery Combined with Neoadjuvant Chemotherapy on Breast Cancer

目的分析保乳术结合新辅助化疗法治疗乳腺癌的临床效果。方法选取对象为本院收治的86例乳腺癌患者,时间为2015年6月至2019年6月。入院分组时采用数字随机法,将86例患者分为对照组(43例)、试验组(43例)。对照组采取传统根治术治疗,试验组则采取保乳术结合新辅助化疗法进行治疗。对比两组疗效情况。结果试验组术后复发率和转移率略低于对照组,但组间数据差异不大,无统计学意义(P>0.05);试验组术中出血量、手术时间、住院时间、拔管时间均低于对照组,组间数据差异具有统计学意义(P<0.05);试验组各项生活质量评分均高于对照组,而术后并发症发生率也比对照组低,组间数据差异具有统计学意义(P<0.05)。结论对乳腺癌患者采取保乳术结合新辅助化疗法,既能减少出血量,缩短手术时间,又能降低并发症发生率,提高后期生活质量,值得临床应用。

Objective To analyze the clinical effect of breast preservation combined with neoadjuvant therapy in the treatment of breast cancer.Methods Eighty-six breast cancer patients were selected,date is June 2015 to June 2019.A digital randomization approach,86 patients were divided into control group(43)and experimental group(43).The control group was treated with traditional radical surgery,the experimental group was treated with breast preservation combined with neoadjuvant therapy.The curative effect of the two groups was compared.Results The postoperative recurrence rate and metastasis rate in the experimental group were slightly lower than those in the control group,but there was little difference between groups,no statistical significance(P>0.05).The blood loss,operation,hospitalization and extubation time in the experimental group were lower than those in the control group,data difference between groups was statistically significant(P<0.05).The scores of quality of life in the experimental group were higher than those in the control group,the postoperative complication rate was lower than that of the control group,data difference between groups was statistically significant(P<0.05).Conclusion Breast-preserving combined with neoadjuvant therapy for breast cancer patients,to reduce the bleeding,shortening the operation time,and reduce complications,to improve the quality of life at a later stage,it is worthy of clinical application.